Global Infusion Pump Market Size study & Forecast, by Type (Volumetric Pumps, Syringe Pumps, Enteral Pumps, Insulin Pumps, Elastomeric Pumps, Implantable Pumps, and PCA Pumps), Application (Diabetes, Oncology, Pain Management, and Others), End User (Hospi

The Global Infusion Pump Market, valued at approximately USD 11.94 billion in 2024, is poised to register a compound annual growth rate of about 7.40% between 2025 and 2035, reaching an estimated USD 26.18 billion by the end of the forecast period. Infusion pumps—essential medical devices designed to deliver fluids, nutrients, or medications into a patient’s body in controlled amounts—are becoming indispensable in modern healthcare systems. Their precision, programmability, and adaptability to diverse therapeutic applications have made them critical in acute care settings, chronic disease management, and home healthcare. Market expansion is largely underpinned by the rising global prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders, along with the growing geriatric population that demands prolonged and complex treatment regimens. Furthermore, advancements in pump technology, including integration with electronic medical records, wireless connectivity, and smart alert systems, are enabling healthcare providers to improve patient safety while reducing human error in medication administration.

A growing emphasis on outpatient care and home-based treatment solutions is further propelling demand for compact, portable, and patient-friendly infusion pump models. This shift aligns with the broader healthcare trend toward cost containment, reduced hospital stays, and improved quality of life for patients managing long-term illnesses. Technological innovations—such as closed-loop systems for insulin delivery, sensor-assisted oncology pumps, and automated drug libraries—are reshaping market dynamics by offering more personalized and adaptive therapies. Additionally, the surge in demand for infusion therapy in oncology, pain management, and critical care, coupled with rapid product approvals and regulatory clearances, has accelerated the pace of adoption worldwide. However, concerns around device malfunctions, cybersecurity threats to connected devices, and the high costs of advanced pump systems remain notable hurdles for widespread implementation in emerging economies.

Regionally, North America accounted for the largest revenue share in 2024, benefiting from advanced healthcare infrastructure, high adoption rates of cutting-edge medical devices, and a well-established reimbursement framework. The U.S., in particular, remains a lucrative market due to its strong focus on integrating smart infusion systems within hospital networks and home healthcare programs. Europe follows closely, driven by robust government support for healthcare modernization, an expanding elderly population, and increasing investments in automated drug delivery systems. Asia Pacific is projected to witness the fastest growth through 2035, spurred by surging healthcare expenditure, rapid hospital infrastructure development, and rising incidences of lifestyle-related diseases in densely populated nations such as China and India. Moreover, government-led initiatives to improve access to essential medical devices, coupled with the expansion of private healthcare providers, are creating fertile grounds for infusion pump adoption in the region.

Major market player included in this report are:
• Baxter International Inc.
• B. Braun Melsungen AG
• ICU Medical, Inc.
• Fresenius Kabi AG
• Terumo Corporation
• Smiths Medical (ICU Medical)
• Medtronic plc
• Moog Inc.
• BD (Becton, Dickinson and Company)
• Nipro Corporation
• JMS Co., Ltd.
• Roche Diagnostics
• Zyno Medical
• Mindray Medical International Limited
• AngioDynamics Inc.

Global Infusion Pump Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Type:
• Volumetric Pumps
• Syringe Pumps
• Enteral Pumps
• Insulin Pumps
• Elastomeric Pumps
• Implantable Pumps
• PCA Pumps

By Application:
• Diabetes
• Oncology
• Pain Management
• Others

By End User:
• Hospitals & Clinics
• Ambulatory Care Settings
• Home Care Settings
• Others

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more